Holders · period archive

CTMX · Cytomx Therapeutics Inc.

Q3 2019 13F holders

← latest ownership dossier

Ticker: CTMX
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares